PRICE T ROWE ASSOCIATES INC /MD/

Position in ORKA — Oruka Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in ORKA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,681,373

+$15,999,697 QoQ

Shares Held

727,449

+12.0% QoQ

Ownership

1.21%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 99.83751438245156.ToString("F0")% Shared 0.ToString("F0")% None 0.16248561754844668.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. ORKA ranks #64 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713
8	SRRK	Scholar Rock Holding Corp	6,206,618	$305,117,340

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,681,373	727,449	+12.0%	Shares	Defined	2026-05-15
2025-12-31	$19,681,676	649,346	+3.6%	Shares	Sole	2026-02-17
2025-09-30	$12,053,478	626,806	+52.6%	Shares	Sole	2025-11-14
2025-06-30	$4,605,975	410,881	-0.2%	Shares	Sole	2025-08-14
2025-03-31	$4,223,036	411,602	-69.0%	Shares	Sole	2025-05-14
2024-12-31	$25,728,454	1,326,893	+374.5%	Shares	Sole	2025-02-14
2024-09-30	$6,854,172	279,648	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.